Electromed (NYSEAMERICAN:ELMD) Shares Cross Above Two Hundred Day Moving Average of $0.00

Electromed, Inc. (NYSEAMERICAN:ELMD – Get Rating)’s stock price passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.00 and traded as high as $10.60. Electromed shares last traded at $10.54, with a volume of 7,993 shares trading hands.

Analysts Set New Price Targets

Separately, Lake Street Capital assumed coverage on Electromed in a report on Wednesday, December 28th. They issued a “buy” rating and a $20.00 target price on the stock. Four investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $16.75.

Electromed Stock Up 0.9 %

The stock has a market cap of $89.43 million, a PE ratio of 47.91 and a beta of 0.48.

Electromed (NYSEAMERICAN:ELMD – Get Rating) last issued its quarterly earnings data on Tuesday, November 8th. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter. Electromed had a return on equity of 5.73% and a net margin of 4.60%. The business had revenue of $10.66 million for the quarter.

Institutional Trading of Electromed

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Annex Advisory Services LLC lifted its position in Electromed by 7.4% during the third quarter. Annex Advisory Services LLC now owns 22,666 shares of the medical equipment provider’s stock worth $232,000 after buying an additional 1,558 shares during the period. Vanguard Group Inc. lifted its position in Electromed by 2.6% during the first quarter. Vanguard Group Inc. now owns 310,200 shares of the medical equipment provider’s stock worth $3,859,000 after buying an additional 7,742 shares during the period. Dimensional Fund Advisors LP lifted its position in Electromed by 1.5% during the first quarter. Dimensional Fund Advisors LP now owns 268,711 shares of the medical equipment provider’s stock worth $3,343,000 after buying an additional 3,906 shares during the period. Royal Bank of Canada lifted its position in Electromed by 4.1% during the first quarter. Royal Bank of Canada now owns 99,252 shares of the medical equipment provider’s stock worth $1,235,000 after buying an additional 3,941 shares during the period. Finally, State Street Corp lifted its position in Electromed by 23.3% during the first quarter. State Street Corp now owns 14,529 shares of the medical equipment provider’s stock worth $181,000 after buying an additional 2,742 shares during the period. 31.95% of the stock is currently owned by hedge funds and other institutional investors.

Electromed Company Profile

(Get Rating)

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.